

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of other organism (GO:0098543) | 4.69743165 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 4.63481346 |
| 3 | detection of external biotic stimulus (GO:0098581) | 4.31830008 |
| 4 | detection of bacterium (GO:0016045) | 4.19574285 |
| 5 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.12711322 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.92107977 |
| 7 | negative regulation of cell killing (GO:0031342) | 3.92107977 |
| 8 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.90791566 |
| 9 | detection of biotic stimulus (GO:0009595) | 3.84444459 |
| 10 | regulation of mast cell degranulation (GO:0043304) | 3.81212475 |
| 11 | microglial cell activation (GO:0001774) | 3.70684845 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.70243865 |
| 13 | IMP biosynthetic process (GO:0006188) | 3.61674991 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.59252877 |
| 15 | positive regulation of mast cell activation (GO:0033005) | 3.56349097 |
| 16 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.56100195 |
| 17 | regulation of leukocyte degranulation (GO:0043300) | 3.55719940 |
| 18 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.55547738 |
| 19 | macrophage activation (GO:0042116) | 3.48518211 |
| 20 | response to muramyl dipeptide (GO:0032495) | 3.43680846 |
| 21 | regulation of mast cell activation (GO:0033003) | 3.37958861 |
| 22 | myeloid cell activation involved in immune response (GO:0002275) | 3.36691376 |
| 23 | IMP metabolic process (GO:0046040) | 3.34349169 |
| 24 | T-helper 1 type immune response (GO:0042088) | 3.32416913 |
| 25 | neutrophil mediated immunity (GO:0002446) | 3.32376181 |
| 26 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.28230895 |
| 27 | positive regulation of mast cell degranulation (GO:0043306) | 3.28230895 |
| 28 | nuclear pore complex assembly (GO:0051292) | 3.27622284 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.26949305 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.26949305 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.26949305 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.26949305 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.26949305 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.26949305 |
| 35 | nuclear pore organization (GO:0006999) | 3.26566351 |
| 36 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.23826027 |
| 37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.22304374 |
| 38 | regulation of antigen processing and presentation (GO:0002577) | 3.13487788 |
| 39 | determination of adult lifespan (GO:0008340) | 3.13430316 |
| 40 | positive regulation of leukocyte degranulation (GO:0043302) | 3.13421573 |
| 41 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.13062818 |
| 42 | oligosaccharide catabolic process (GO:0009313) | 3.12838879 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11700144 |
| 44 | response to host (GO:0075136) | 3.11700144 |
| 45 | response to host defenses (GO:0052200) | 3.11700144 |
| 46 | defense response to protozoan (GO:0042832) | 3.10433548 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.10163463 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.08660918 |
| 49 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.06153620 |
| 50 | negative regulation of interleukin-17 production (GO:0032700) | 3.05810130 |
| 51 | regulation of macrophage cytokine production (GO:0010935) | 3.03514613 |
| 52 | response to protozoan (GO:0001562) | 3.02865805 |
| 53 | B cell mediated immunity (GO:0019724) | 3.02641101 |
| 54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02170943 |
| 55 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00452100 |
| 56 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.96459705 |
| 57 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96246161 |
| 58 | germinal center formation (GO:0002467) | 2.94088659 |
| 59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.94062231 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94062231 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93633532 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 2.92987552 |
| 63 | positive regulation of macrophage cytokine production (GO:0060907) | 2.90663490 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.90376865 |
| 65 | tetrahydrofolate metabolic process (GO:0046653) | 2.89925258 |
| 66 | regulation of interferon-alpha production (GO:0032647) | 2.89335653 |
| 67 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.86934679 |
| 68 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.86189361 |
| 69 | pore complex assembly (GO:0046931) | 2.85509293 |
| 70 | regulation of regulated secretory pathway (GO:1903305) | 2.82929608 |
| 71 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.82826938 |
| 72 | regulation of helicase activity (GO:0051095) | 2.82281490 |
| 73 | negative regulation of interleukin-6 production (GO:0032715) | 2.82084972 |
| 74 | myeloid leukocyte mediated immunity (GO:0002444) | 2.80180819 |
| 75 | glycosphingolipid catabolic process (GO:0046479) | 2.79518106 |
| 76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79298219 |
| 77 | leukocyte aggregation (GO:0070486) | 2.77483561 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 2.75585131 |
| 79 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.75540087 |
| 80 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.73041280 |
| 81 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.72552921 |
| 82 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.71663323 |
| 83 | regulation of gene silencing by miRNA (GO:0060964) | 2.71663323 |
| 84 | regulation of gene silencing by RNA (GO:0060966) | 2.71663323 |
| 85 | pinocytosis (GO:0006907) | 2.69717911 |
| 86 | negative regulation of T cell mediated immunity (GO:0002710) | 2.69284714 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.69001164 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.68769080 |
| 89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.68629750 |
| 90 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.66290303 |
| 91 | myeloid leukocyte activation (GO:0002274) | 2.66030598 |
| 92 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.65893345 |
| 93 | DNA replication initiation (GO:0006270) | 2.63372229 |
| 94 | regulation of tolerance induction (GO:0002643) | 2.62904047 |
| 95 | negative regulation of innate immune response (GO:0045824) | 2.62601716 |
| 96 | positive regulation of interferon-beta production (GO:0032728) | 2.59302673 |
| 97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57907000 |
| 98 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.56657849 |
| 99 | nucleobase biosynthetic process (GO:0046112) | 2.56117115 |
| 100 | response to interferon-beta (GO:0035456) | 2.52638306 |
| 101 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.51145295 |
| 102 | response to peptidoglycan (GO:0032494) | 2.45203594 |
| 103 | purine nucleobase biosynthetic process (GO:0009113) | 2.42936786 |
| 104 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.41713110 |
| 105 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.41713110 |
| 106 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.41450627 |
| 107 | embryonic process involved in female pregnancy (GO:0060136) | 2.40483761 |
| 108 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.38424247 |
| 109 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.38326209 |
| 110 | DNA geometric change (GO:0032392) | 2.38304867 |
| 111 | folic acid-containing compound metabolic process (GO:0006760) | 2.37202238 |
| 112 | macrophage activation involved in immune response (GO:0002281) | 2.36519014 |
| 113 | positive regulation of B cell differentiation (GO:0045579) | 2.35986614 |
| 114 | DNA duplex unwinding (GO:0032508) | 2.35743328 |
| 115 | detection of molecule of bacterial origin (GO:0032490) | 2.34393058 |
| 116 | DNA strand elongation (GO:0022616) | 2.32682220 |
| 117 | mitotic nuclear envelope disassembly (GO:0007077) | 2.31822920 |
| 118 | peptide catabolic process (GO:0043171) | 2.29500781 |
| 119 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.29013554 |
| 120 | regulation of gene silencing (GO:0060968) | 2.28520848 |
| 121 | valine metabolic process (GO:0006573) | 2.27832565 |
| 122 | cellular response to interferon-beta (GO:0035458) | 2.25652900 |
| 123 | DNA unwinding involved in DNA replication (GO:0006268) | 2.24147374 |
| 124 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.19922680 |
| 125 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.19408746 |
| 126 | response to interferon-alpha (GO:0035455) | 2.19269971 |
| 127 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.17868051 |
| 128 | respiratory burst (GO:0045730) | 2.17209353 |
| 129 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.16161899 |
| 130 | response to host immune response (GO:0052572) | 2.16161899 |
| 131 | Golgi transport vesicle coating (GO:0048200) | 2.15370981 |
| 132 | COPI coating of Golgi vesicle (GO:0048205) | 2.15370981 |
| 133 | protein K6-linked ubiquitination (GO:0085020) | 2.14297383 |
| 134 | formation of translation preinitiation complex (GO:0001731) | 2.13637627 |
| 135 | folic acid metabolic process (GO:0046655) | 2.12852998 |
| 136 | negative regulation of B cell proliferation (GO:0030889) | 2.10362669 |
| 137 | regulation of chromatin silencing (GO:0031935) | 2.09517772 |
| 138 | regulation of translational fidelity (GO:0006450) | 2.08609061 |
| 139 | granulocyte activation (GO:0036230) | 2.07741103 |
| 140 | basic amino acid transport (GO:0015802) | 2.07557595 |
| 141 | embryonic placenta development (GO:0001892) | 2.07218319 |
| 142 | membrane disassembly (GO:0030397) | 2.06110966 |
| 143 | nuclear envelope disassembly (GO:0051081) | 2.06110966 |
| 144 | pteridine-containing compound metabolic process (GO:0042558) | 2.04563697 |
| 145 | neutrophil activation (GO:0042119) | 2.04377672 |
| 146 | toxin transport (GO:1901998) | 1.99568903 |
| 147 | glycine metabolic process (GO:0006544) | 1.99295579 |
| 148 | regulation of interferon-beta production (GO:0032648) | 1.99168740 |
| 149 | cytokine secretion (GO:0050663) | 1.98989740 |
| 150 | urate metabolic process (GO:0046415) | 1.98668055 |
| 151 | positive regulation of antigen processing and presentation (GO:0002579) | 1.98353598 |
| 152 | regulation of histone H3-K9 methylation (GO:0051570) | 1.97583496 |
| 153 | antigen processing and presentation via MHC class Ib (GO:0002475) | 1.97329984 |
| 154 | cellular extravasation (GO:0045123) | 1.97125388 |
| 155 | telomere maintenance via recombination (GO:0000722) | 1.96423405 |
| 156 | regulation of B cell differentiation (GO:0045577) | 1.96418505 |
| 157 | regulation of gamma-delta T cell differentiation (GO:0045586) | 1.96417976 |
| 158 | regulation of protein import into nucleus, translocation (GO:0033158) | 1.96267518 |
| 159 | mismatch repair (GO:0006298) | 1.95996539 |
| 160 | L-alpha-amino acid transmembrane transport (GO:1902475) | 1.95978211 |
| 161 | protein localization to kinetochore (GO:0034501) | 1.95683824 |
| 162 | natural killer cell mediated cytotoxicity (GO:0042267) | 1.95329763 |
| 163 | natural killer cell mediated immunity (GO:0002228) | 1.95329763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.37589756 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.07931276 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.81879955 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76495266 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.61633617 |
| 6 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38725906 |
| 7 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.38119344 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31647916 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.30615022 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25014196 |
| 11 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.24117782 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12917337 |
| 13 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.11470060 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10403172 |
| 15 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.02623556 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01216412 |
| 17 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.96300622 |
| 18 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87604715 |
| 19 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.86644974 |
| 20 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.83841259 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83003273 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82576188 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80554248 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79756871 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76600725 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.76479167 |
| 27 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75633481 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.75490152 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74500904 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73805573 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73466262 |
| 32 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72178490 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.69040503 |
| 34 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.63470419 |
| 35 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.62979509 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61712584 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.61139008 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60745858 |
| 39 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.59761769 |
| 40 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.59761769 |
| 41 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.59761769 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59217412 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56615299 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.55799934 |
| 45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54425998 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.54030590 |
| 47 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.53717927 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53623253 |
| 49 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.51521043 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49420483 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46708108 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46253441 |
| 53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.44676105 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44083753 |
| 55 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.43921390 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.43324722 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.43084401 |
| 58 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40702833 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39475883 |
| 60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39121401 |
| 61 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39062732 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38803094 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36253196 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36097665 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36083013 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34804734 |
| 67 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.34728191 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34311532 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33855153 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33726365 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33343368 |
| 72 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32279120 |
| 73 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31781578 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31671429 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31556859 |
| 76 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.30586337 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28247486 |
| 78 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28187616 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26584360 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26374738 |
| 81 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24958814 |
| 82 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.23692386 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.23095584 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22742770 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22605381 |
| 86 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21297970 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20201640 |
| 88 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.19328629 |
| 89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19178470 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18880738 |
| 91 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18610849 |
| 92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18131519 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18116877 |
| 94 | MYB_26560356_Chip-Seq_TH2_Human | 1.17152815 |
| 95 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16459262 |
| 96 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15648493 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15146692 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14720566 |
| 99 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14613589 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12173291 |
| 101 | MYB_26560356_Chip-Seq_TH1_Human | 1.12111249 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12046117 |
| 103 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11583081 |
| 104 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11538432 |
| 105 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11532507 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10252628 |
| 107 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09999316 |
| 108 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.07365465 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07336032 |
| 110 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07165800 |
| 111 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.07146840 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06409417 |
| 113 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.06321227 |
| 114 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05881896 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05831342 |
| 116 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05088514 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04746424 |
| 118 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04550275 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03946797 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03641098 |
| 121 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03561739 |
| 122 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.01933956 |
| 123 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01538814 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01159574 |
| 125 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01143780 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00463723 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99788621 |
| 128 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97458322 |
| 129 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.97242036 |
| 130 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96454234 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95528749 |
| 132 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95419473 |
| 133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95033749 |
| 134 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94395603 |
| 135 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.94376455 |
| 136 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93781365 |
| 137 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93087985 |
| 138 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93005251 |
| 139 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.92048891 |
| 140 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91632257 |
| 141 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91208059 |
| 142 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90765066 |
| 143 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.88939553 |
| 144 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84211255 |
| 145 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83216625 |
| 146 | MAF_26560356_Chip-Seq_TH2_Human | 0.82332107 |
| 147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82308640 |
| 148 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82308640 |
| 149 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79584227 |
| 150 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.78689973 |
| 151 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.77720747 |
| 152 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77259787 |
| 153 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72287480 |
| 154 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71295268 |
| 155 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.71221740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.41734652 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.56668823 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.50385351 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.49552988 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.39967824 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.16093753 |
| 7 | MP0003436_decreased_susceptibility_to | 2.08814007 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.04285101 |
| 9 | MP0003828_pulmonary_edema | 2.03156880 |
| 10 | MP0003566_abnormal_cell_adhesion | 1.98471776 |
| 11 | MP0005360_urolithiasis | 1.95290993 |
| 12 | MP0010307_abnormal_tumor_latency | 1.94404442 |
| 13 | MP0008057_abnormal_DNA_replication | 1.90331517 |
| 14 | MP0006082_CNS_inflammation | 1.90091265 |
| 15 | MP0010094_abnormal_chromosome_stability | 1.89051899 |
| 16 | MP0000604_amyloidosis | 1.85268849 |
| 17 | MP0009785_altered_susceptibility_to | 1.74730676 |
| 18 | MP0002419_abnormal_innate_immunity | 1.73334480 |
| 19 | MP0002396_abnormal_hematopoietic_system | 1.71155554 |
| 20 | MP0008260_abnormal_autophagy | 1.70710349 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.64277816 |
| 22 | MP0008058_abnormal_DNA_repair | 1.60849657 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 1.59974441 |
| 24 | MP0003111_abnormal_nucleus_morphology | 1.59537405 |
| 25 | MP0002998_abnormal_bone_remodeling | 1.58893090 |
| 26 | MP0005025_abnormal_response_to | 1.58859790 |
| 27 | MP0003075_altered_response_to | 1.58545092 |
| 28 | MP0003077_abnormal_cell_cycle | 1.58125342 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.55164497 |
| 30 | MP0009840_abnormal_foam_cell | 1.54215877 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.51936852 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.51401779 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.51102090 |
| 34 | MP0001800_abnormal_humoral_immune | 1.48629011 |
| 35 | MP0003186_abnormal_redox_activity | 1.47855635 |
| 36 | MP0000371_diluted_coat_color | 1.47505238 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.46780066 |
| 38 | MP0000490_abnormal_crypts_of | 1.45326583 |
| 39 | MP0005451_abnormal_body_composition | 1.44851416 |
| 40 | MP0003690_abnormal_glial_cell | 1.42421555 |
| 41 | MP0002254_reproductive_system_inflammat | 1.41385963 |
| 42 | MP0000685_abnormal_immune_system | 1.40875577 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.37810972 |
| 44 | MP0000569_abnormal_digit_pigmentation | 1.37224729 |
| 45 | MP0008007_abnormal_cellular_replicative | 1.35949913 |
| 46 | MP0000858_altered_metastatic_potential | 1.35474018 |
| 47 | * MP0003172_abnormal_lysosome_physiology | 1.34911860 |
| 48 | MP0004883_abnormal_blood_vessel | 1.33615239 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.33511108 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.32632933 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.32366413 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.31301200 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.31301200 |
| 54 | MP0002723_abnormal_immune_serum | 1.30896953 |
| 55 | MP0001790_abnormal_immune_system | 1.30043609 |
| 56 | MP0005387_immune_system_phenotype | 1.30043609 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.28941343 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.28874196 |
| 59 | MP0001819_abnormal_immune_cell | 1.27412307 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.27243342 |
| 61 | MP0005164_abnormal_response_to | 1.26705263 |
| 62 | MP0003448_altered_tumor_morphology | 1.26358124 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.26278255 |
| 64 | MP0005023_abnormal_wound_healing | 1.25450781 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.25205532 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.25133566 |
| 67 | MP0008004_abnormal_stomach_pH | 1.24832059 |
| 68 | MP0003252_abnormal_bile_duct | 1.24027374 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.23330373 |
| 70 | MP0002405_respiratory_system_inflammati | 1.22617069 |
| 71 | MP0005671_abnormal_response_to | 1.22279364 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.21679011 |
| 73 | MP0003724_increased_susceptibility_to | 1.19291760 |
| 74 | MP0005365_abnormal_bile_salt | 1.16418930 |
| 75 | MP0002398_abnormal_bone_marrow | 1.15781010 |
| 76 | MP0008469_abnormal_protein_level | 1.13592395 |
| 77 | MP0002136_abnormal_kidney_physiology | 1.11395982 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.10259645 |
| 79 | MP0004019_abnormal_vitamin_homeostasis | 1.10114086 |
| 80 | MP0003195_calcinosis | 1.09931167 |
| 81 | * MP0000716_abnormal_immune_system | 1.08681375 |
| 82 | MP0002722_abnormal_immune_system | 1.07659575 |
| 83 | * MP0002429_abnormal_blood_cell | 1.07029190 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 1.06495221 |
| 85 | MP0002132_abnormal_respiratory_system | 1.05973072 |
| 86 | MP0001853_heart_inflammation | 1.05176312 |
| 87 | MP0002019_abnormal_tumor_incidence | 1.03042179 |
| 88 | MP0001851_eye_inflammation | 1.02909290 |
| 89 | MP0001915_intracranial_hemorrhage | 1.01877401 |
| 90 | MP0009763_increased_sensitivity_to | 1.00094702 |
| 91 | MP0006054_spinal_hemorrhage | 1.00038849 |
| 92 | MP0009278_abnormal_bone_marrow | 0.99756029 |
| 93 | MP0005166_decreased_susceptibility_to | 0.98038926 |
| 94 | MP0001730_embryonic_growth_arrest | 0.98012731 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.96254059 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.95429538 |
| 97 | MP0004510_myositis | 0.94877976 |
| 98 | MP0000343_altered_response_to | 0.94741777 |
| 99 | MP0000609_abnormal_liver_physiology | 0.94046086 |
| 100 | MP0002086_abnormal_extraembryonic_tissu | 0.93938793 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.93767845 |
| 102 | MP0005332_abnormal_amino_acid | 0.93139052 |
| 103 | MP0000350_abnormal_cell_proliferation | 0.93109694 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 0.90474834 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.89819156 |
| 106 | * MP0000598_abnormal_liver_morphology | 0.89495084 |
| 107 | MP0003283_abnormal_digestive_organ | 0.89051169 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.85827946 |
| 109 | MP0005390_skeleton_phenotype | 0.85643807 |
| 110 | MP0002006_tumorigenesis | 0.85197705 |
| 111 | MP0003329_amyloid_beta_deposits | 0.84103898 |
| 112 | MP0003866_abnormal_defecation | 0.83404333 |
| 113 | MP0009764_decreased_sensitivity_to | 0.82433081 |
| 114 | MP0002166_altered_tumor_susceptibility | 0.81679482 |
| 115 | MP0005408_hypopigmentation | 0.80769831 |
| 116 | MP0003091_abnormal_cell_migration | 0.80694221 |
| 117 | MP0003763_abnormal_thymus_physiology | 0.80576312 |
| 118 | MP0003795_abnormal_bone_structure | 0.80248084 |
| 119 | MP0000249_abnormal_blood_vessel | 0.79071448 |
| 120 | MP0010234_abnormal_vibrissa_follicle | 0.78849044 |
| 121 | MP0001764_abnormal_homeostasis | 0.78656464 |
| 122 | MP0005310_abnormal_salivary_gland | 0.77633119 |
| 123 | MP0000313_abnormal_cell_death | 0.77495172 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.76596802 |
| 125 | MP0004947_skin_inflammation | 0.76592269 |
| 126 | MP0001849_ear_inflammation | 0.75354380 |
| 127 | MP0002075_abnormal_coat/hair_pigmentati | 0.71574906 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.71383538 |
| 129 | MP0003453_abnormal_keratinocyte_physiol | 0.70920442 |
| 130 | MP0005165_increased_susceptibility_to | 0.69530513 |
| 131 | MP0002933_joint_inflammation | 0.68403392 |
| 132 | MP0005075_abnormal_melanosome_morpholog | 0.67144048 |
| 133 | MP0002009_preneoplasia | 0.64963867 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.64256459 |
| 135 | MP0003279_aneurysm | 0.64194732 |
| 136 | MP0001663_abnormal_digestive_system | 0.63775777 |
| 137 | MP0001958_emphysema | 0.62378744 |
| 138 | MP0000920_abnormal_myelination | 0.60240034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agnosia (HP:0010524) | 3.98921225 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.84538625 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 3.56600130 |
| 4 | Loss of speech (HP:0002371) | 3.37993849 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.34187111 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.29320036 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20142460 |
| 8 | Obstructive lung disease (HP:0006536) | 3.20142460 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.17240032 |
| 10 | Stomatitis (HP:0010280) | 3.17221499 |
| 11 | Amyloidosis (HP:0011034) | 3.16385003 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.15364964 |
| 13 | Disinhibition (HP:0000734) | 3.09179276 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.05114249 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.90706785 |
| 16 | Meningitis (HP:0001287) | 2.90138541 |
| 17 | Mucopolysacchariduria (HP:0008155) | 2.85531272 |
| 18 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85531272 |
| 19 | Prolonged bleeding time (HP:0003010) | 2.82619268 |
| 20 | Vasculitis (HP:0002633) | 2.73613375 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.73032350 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.73032350 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.73032350 |
| 24 | T lymphocytopenia (HP:0005403) | 2.70419049 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.69984108 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 2.69007792 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.68359233 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 2.67309432 |
| 29 | Peritonitis (HP:0002586) | 2.66614608 |
| 30 | Pulmonary infiltrates (HP:0002113) | 2.66499567 |
| 31 | Urticaria (HP:0001025) | 2.65386320 |
| 32 | Chest pain (HP:0100749) | 2.62045711 |
| 33 | Metaphyseal cupping (HP:0003021) | 2.59564597 |
| 34 | Purpura (HP:0000979) | 2.55412722 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.54994973 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.54994973 |
| 37 | Cellulitis (HP:0100658) | 2.54549748 |
| 38 | Abnormality of T cell number (HP:0011839) | 2.51130788 |
| 39 | Hemoptysis (HP:0002105) | 2.50428017 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.44944971 |
| 41 | IgM deficiency (HP:0002850) | 2.43299121 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.42854764 |
| 43 | Chromsome breakage (HP:0040012) | 2.40622398 |
| 44 | Colitis (HP:0002583) | 2.39713983 |
| 45 | Spastic diplegia (HP:0001264) | 2.37664667 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.37601787 |
| 47 | Joint hemorrhage (HP:0005261) | 2.37367026 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36795312 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.36696805 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.36531089 |
| 51 | Amaurosis fugax (HP:0100576) | 2.36175069 |
| 52 | Myositis (HP:0100614) | 2.36088991 |
| 53 | Leukocytosis (HP:0001974) | 2.35707014 |
| 54 | Glomerulonephritis (HP:0000099) | 2.34301210 |
| 55 | Ependymoma (HP:0002888) | 2.33720307 |
| 56 | Pulmonary embolism (HP:0002204) | 2.33609150 |
| 57 | Thrombocytosis (HP:0001894) | 2.30129553 |
| 58 | Encephalitis (HP:0002383) | 2.30012385 |
| 59 | Esophageal varix (HP:0002040) | 2.29658030 |
| 60 | Increased serum ferritin (HP:0003281) | 2.29006954 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.26767463 |
| 62 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.20074044 |
| 63 | Upper motor neuron abnormality (HP:0002127) | 2.18879322 |
| 64 | Episodic fever (HP:0001954) | 2.17656128 |
| 65 | Hepatosplenomegaly (HP:0001433) | 2.16225660 |
| 66 | Mediastinal lymphadenopathy (HP:0100721) | 2.15972505 |
| 67 | * Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.13711801 |
| 68 | Abnormality of iron homeostasis (HP:0011031) | 2.12557255 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.10558294 |
| 70 | Spondylolisthesis (HP:0003302) | 2.10051448 |
| 71 | Birth length less than 3rd percentile (HP:0003561) | 2.08547282 |
| 72 | Intrahepatic cholestasis (HP:0001406) | 2.06096089 |
| 73 | Pathologic fracture (HP:0002756) | 2.04792703 |
| 74 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04450703 |
| 75 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.02982964 |
| 76 | Acute hepatic failure (HP:0006554) | 2.02260109 |
| 77 | Abnormality of chromosome stability (HP:0003220) | 2.02158789 |
| 78 | Viral hepatitis (HP:0006562) | 2.00946075 |
| 79 | Abnormality of nucleobase metabolism (HP:0010932) | 2.00775502 |
| 80 | Complement deficiency (HP:0004431) | 1.99475142 |
| 81 | Periodontitis (HP:0000704) | 1.99465502 |
| 82 | Abnormality of the peritoneum (HP:0002585) | 1.98273503 |
| 83 | Polyneuropathy (HP:0001271) | 1.97820314 |
| 84 | Anorexia (HP:0002039) | 1.96909385 |
| 85 | Progressive neurologic deterioration (HP:0002344) | 1.96508254 |
| 86 | Recurrent fungal infections (HP:0002841) | 1.92968140 |
| 87 | Gangrene (HP:0100758) | 1.92806012 |
| 88 | Neurofibrillary tangles (HP:0002185) | 1.91800675 |
| 89 | Gingivitis (HP:0000230) | 1.91267098 |
| 90 | Abnormality of the lumbar spine (HP:0100712) | 1.90817951 |
| 91 | Abnormality of complement system (HP:0005339) | 1.90220201 |
| 92 | Basal ganglia calcification (HP:0002135) | 1.89280803 |
| 93 | Orchitis (HP:0100796) | 1.88558172 |
| 94 | Gingival bleeding (HP:0000225) | 1.88527900 |
| 95 | Abnormality of the pleura (HP:0002103) | 1.88390501 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 1.87861704 |
| 97 | Abnormality of T cells (HP:0002843) | 1.87215955 |
| 98 | Mutism (HP:0002300) | 1.86498001 |
| 99 | Cervical subluxation (HP:0003308) | 1.86118915 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85843780 |
| 101 | Recurrent viral infections (HP:0004429) | 1.85824566 |
| 102 | Cortical dysplasia (HP:0002539) | 1.85376457 |
| 103 | Autoimmune hemolytic anemia (HP:0001890) | 1.84795686 |
| 104 | Restrictive lung disease (HP:0002091) | 1.83589324 |
| 105 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.82891207 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 1.82788702 |
| 107 | Arterial thrombosis (HP:0004420) | 1.82289628 |
| 108 | Agammaglobulinemia (HP:0004432) | 1.82011472 |
| 109 | Axonal loss (HP:0003447) | 1.81373788 |
| 110 | Spinal muscular atrophy (HP:0007269) | 1.81323289 |
| 111 | Glomerulopathy (HP:0100820) | 1.80815523 |
| 112 | Chronic diarrhea (HP:0002028) | 1.80785398 |
| 113 | Hyperactive renin-angiotensin system (HP:0000841) | 1.79736870 |
| 114 | Vaginal fistula (HP:0004320) | 1.77744632 |
| 115 | Myocardial infarction (HP:0001658) | 1.77635364 |
| 116 | Ascites (HP:0001541) | 1.76905378 |
| 117 | Distal lower limb muscle weakness (HP:0009053) | 1.76675963 |
| 118 | Pustule (HP:0200039) | 1.76065453 |
| 119 | Reticulocytopenia (HP:0001896) | 1.74681200 |
| 120 | Rectal fistula (HP:0100590) | 1.74296349 |
| 121 | Rectovaginal fistula (HP:0000143) | 1.74296349 |
| 122 | Hypoglycemic coma (HP:0001325) | 1.74257545 |
| 123 | Leukopenia (HP:0001882) | 1.73807201 |
| 124 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73262570 |
| 125 | Abnormality of glycolipid metabolism (HP:0010969) | 1.73146010 |
| 126 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.73146010 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.73146010 |
| 128 | Recurrent skin infections (HP:0001581) | 1.72454019 |
| 129 | Reduced antithrombin III activity (HP:0001976) | 1.71091991 |
| 130 | Abnormality of the common coagulation pathway (HP:0010990) | 1.69793746 |
| 131 | Renal salt wasting (HP:0000127) | 1.69667781 |
| 132 | Osteomyelitis (HP:0002754) | 1.68270975 |
| 133 | Rhabdomyosarcoma (HP:0002859) | 1.68233701 |
| 134 | Intestinal fistula (HP:0100819) | 1.67500074 |
| 135 | Abnormality of T cell physiology (HP:0011840) | 1.66971702 |
| 136 | Hepatocellular carcinoma (HP:0001402) | 1.66163206 |
| 137 | Menorrhagia (HP:0000132) | 1.64851400 |
| 138 | Petechiae (HP:0000967) | 1.64820664 |
| 139 | Neoplasm of the oral cavity (HP:0100649) | 1.63890136 |
| 140 | Generalized aminoaciduria (HP:0002909) | 1.63785558 |
| 141 | Epistaxis (HP:0000421) | 1.63446623 |
| 142 | Hematochezia (HP:0002573) | 1.63016225 |
| 143 | Portal hypertension (HP:0001409) | 1.62777229 |
| 144 | Nausea (HP:0002018) | 1.62262418 |
| 145 | Nephritis (HP:0000123) | 1.62216582 |
| 146 | Medulloblastoma (HP:0002885) | 1.61513304 |
| 147 | IgA deficiency (HP:0002720) | 1.60415806 |
| 148 | Delayed puberty (HP:0000823) | 1.60402547 |
| 149 | Myelodysplasia (HP:0002863) | 1.60206068 |
| 150 | Hydroxyprolinuria (HP:0003080) | 1.59693607 |
| 151 | Abnormality of proline metabolism (HP:0010907) | 1.59693607 |
| 152 | Type I transferrin isoform profile (HP:0003642) | 1.59460043 |
| 153 | Abnormality of lateral ventricle (HP:0030047) | 1.59113594 |
| 154 | Retrobulbar optic neuritis (HP:0100654) | 1.57373105 |
| 155 | Optic neuritis (HP:0100653) | 1.57373105 |
| 156 | Hyperglycinuria (HP:0003108) | 1.57276573 |
| 157 | Thrombophlebitis (HP:0004418) | 1.56930392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.72594034 |
| 2 | FLT3 | 3.07824893 |
| 3 | EPHA2 | 3.00163921 |
| 4 | CDK12 | 2.24017412 |
| 5 | PKN2 | 2.20716832 |
| 6 | FES | 2.19168752 |
| 7 | FGR | 2.16250089 |
| 8 | MAP3K14 | 2.10296011 |
| 9 | PASK | 1.99115678 |
| 10 | MAP3K13 | 1.98634482 |
| 11 | GRK7 | 1.98255382 |
| 12 | MAP4K1 | 1.97614777 |
| 13 | TGFBR2 | 1.95022741 |
| 14 | STK10 | 1.94669503 |
| 15 | BMPR2 | 1.92369628 |
| 16 | RPS6KB2 | 1.85941775 |
| 17 | TYK2 | 1.82730749 |
| 18 | MAPKAPK3 | 1.82675862 |
| 19 | WEE1 | 1.81719992 |
| 20 | KIT | 1.76936247 |
| 21 | MAPK15 | 1.68469706 |
| 22 | BLK | 1.66925949 |
| 23 | BRD4 | 1.66899536 |
| 24 | NME2 | 1.60158832 |
| 25 | TAOK3 | 1.59872592 |
| 26 | GRK6 | 1.58982713 |
| 27 | JAK3 | 1.56692675 |
| 28 | SCYL2 | 1.56605470 |
| 29 | PIM1 | 1.47505565 |
| 30 | PAK4 | 1.46495272 |
| 31 | ERN1 | 1.41943450 |
| 32 | TGFBR1 | 1.41387204 |
| 33 | PRPF4B | 1.40810422 |
| 34 | STK4 | 1.40239908 |
| 35 | ZAK | 1.39882474 |
| 36 | IRAK4 | 1.37987563 |
| 37 | MST4 | 1.36977176 |
| 38 | CSK | 1.34317247 |
| 39 | IRAK3 | 1.33854568 |
| 40 | TTK | 1.31482779 |
| 41 | NEK9 | 1.27993931 |
| 42 | EIF2AK3 | 1.25221600 |
| 43 | EEF2K | 1.22575217 |
| 44 | NEK1 | 1.20917374 |
| 45 | CSF1R | 1.20434298 |
| 46 | FGFR3 | 1.19088838 |
| 47 | CDC7 | 1.18524039 |
| 48 | ATR | 1.17956785 |
| 49 | IKBKB | 1.17560240 |
| 50 | AKT3 | 1.16695961 |
| 51 | TNK2 | 1.16631151 |
| 52 | EIF2AK1 | 1.15843234 |
| 53 | CDK7 | 1.15487122 |
| 54 | TEC | 1.14353720 |
| 55 | IRAK1 | 1.12183529 |
| 56 | SIK3 | 1.11682717 |
| 57 | BTK | 1.10006898 |
| 58 | TBK1 | 1.10003900 |
| 59 | MAP2K3 | 1.09243927 |
| 60 | TSSK6 | 1.07355788 |
| 61 | BCKDK | 1.06773844 |
| 62 | RPS6KA4 | 1.06497049 |
| 63 | TXK | 1.03415466 |
| 64 | ZAP70 | 1.02667373 |
| 65 | TESK2 | 1.02051284 |
| 66 | NEK2 | 1.01825570 |
| 67 | MAP3K8 | 0.98471392 |
| 68 | MAP3K1 | 0.95590309 |
| 69 | ACVR1B | 0.95260634 |
| 70 | PIK3CG | 0.91352045 |
| 71 | MAP3K6 | 0.89647447 |
| 72 | KDR | 0.88408679 |
| 73 | CHUK | 0.87116184 |
| 74 | JAK1 | 0.86199063 |
| 75 | TRPM7 | 0.83360224 |
| 76 | YES1 | 0.83232648 |
| 77 | MAP3K3 | 0.82649281 |
| 78 | CDK4 | 0.82639782 |
| 79 | MET | 0.79892979 |
| 80 | LRRK2 | 0.79199946 |
| 81 | MATK | 0.79108431 |
| 82 | BRSK2 | 0.77589415 |
| 83 | PDK2 | 0.77364947 |
| 84 | PDK1 | 0.75915453 |
| 85 | CDK6 | 0.75733615 |
| 86 | MAPK7 | 0.75613693 |
| 87 | FRK | 0.74395771 |
| 88 | IKBKE | 0.74090674 |
| 89 | AURKB | 0.72074366 |
| 90 | MAP3K2 | 0.71735339 |
| 91 | MAP3K5 | 0.71363023 |
| 92 | IRAK2 | 0.70672035 |
| 93 | FGFR4 | 0.70429696 |
| 94 | PDPK1 | 0.66895319 |
| 95 | TTN | 0.66814566 |
| 96 | PLK1 | 0.66373728 |
| 97 | ITK | 0.65929587 |
| 98 | JAK2 | 0.65480546 |
| 99 | TIE1 | 0.65347321 |
| 100 | LCK | 0.65268564 |
| 101 | CDC42BPA | 0.64818976 |
| 102 | EPHB1 | 0.64306623 |
| 103 | ERBB4 | 0.63547582 |
| 104 | PIM2 | 0.62832919 |
| 105 | MAP3K11 | 0.62686935 |
| 106 | LYN | 0.62241256 |
| 107 | CAMKK2 | 0.61238714 |
| 108 | SRPK1 | 0.61009613 |
| 109 | ABL1 | 0.60848222 |
| 110 | KSR2 | 0.60667318 |
| 111 | HCK | 0.60360140 |
| 112 | VRK1 | 0.59394787 |
| 113 | NLK | 0.59232961 |
| 114 | TAOK2 | 0.58763648 |
| 115 | TESK1 | 0.58717307 |
| 116 | ATM | 0.57564592 |
| 117 | TAOK1 | 0.57036088 |
| 118 | STK3 | 0.55461835 |
| 119 | EIF2AK2 | 0.52924473 |
| 120 | RIPK1 | 0.51923593 |
| 121 | MAP2K6 | 0.51726445 |
| 122 | PRKG2 | 0.51224652 |
| 123 | MOS | 0.50779447 |
| 124 | DDR2 | 0.50178804 |
| 125 | RET | 0.49995824 |
| 126 | STK38L | 0.49857020 |
| 127 | PTK6 | 0.49109945 |
| 128 | MARK2 | 0.48656641 |
| 129 | FYN | 0.48637218 |
| 130 | MARK3 | 0.48464945 |
| 131 | CHEK2 | 0.48260149 |
| 132 | MST1R | 0.48174922 |
| 133 | SYK | 0.48061101 |
| 134 | WNK3 | 0.47664262 |
| 135 | RPS6KA6 | 0.46745435 |
| 136 | BMX | 0.46671892 |
| 137 | RPS6KC1 | 0.43236153 |
| 138 | RPS6KL1 | 0.43236153 |
| 139 | CAMK1D | 0.42383331 |
| 140 | CDK19 | 0.41682288 |
| 141 | SGK3 | 0.39364449 |
| 142 | EGFR | 0.39238997 |
| 143 | PRKCQ | 0.38775827 |
| 144 | PDGFRB | 0.38680401 |
| 145 | EPHA3 | 0.38074009 |
| 146 | NEK6 | 0.37689043 |
| 147 | HIPK2 | 0.37069719 |
| 148 | FER | 0.35568376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.98259813 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.49371185 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.37913296 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.34270662 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23046119 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.13176280 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.00935397 |
| 8 | * Other glycan degradation_Homo sapiens_hsa00511 | 1.96274182 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91265708 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83984900 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67747084 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.66143596 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.65539256 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63387355 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 1.56309492 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.52157097 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51271507 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50567226 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50429598 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49988198 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48601178 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48404893 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45872863 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.45847120 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.45418568 |
| 26 | * Lysosome_Homo sapiens_hsa04142 | 1.43781680 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39967134 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.37885644 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37291376 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33534451 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29614247 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27987987 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27871327 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27283466 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26849155 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25243849 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.24868313 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18126361 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17459876 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17437000 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.12542998 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09549410 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09182570 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08236340 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.04045907 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 1.03889302 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01972934 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 1.00149096 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99495408 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98880636 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.98779765 |
| 52 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.97772352 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96927062 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96046425 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96005528 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95189317 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94447233 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93518121 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.93248133 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92782569 |
| 61 | Cell cycle_Homo sapiens_hsa04110 | 0.90268416 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88725955 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.88395260 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88259980 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.86960910 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86713182 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.86654639 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86289586 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.85843539 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85423778 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85145337 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85131227 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84827395 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83266239 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83019329 |
| 76 | Spliceosome_Homo sapiens_hsa03040 | 0.83003174 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.82606239 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82305216 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81783047 |
| 80 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81321224 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80484237 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80396537 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.80068055 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.79351851 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78570767 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77749683 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77729228 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.77696278 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77650706 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.77423486 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77169879 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76514525 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76474851 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.75298019 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73464698 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73135506 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71867813 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71412090 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70442977 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69652057 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69100508 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66618855 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66065688 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65800119 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65680573 |
| 106 | Allograft rejection_Homo sapiens_hsa05330 | 0.63556211 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61705530 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.60937022 |
| 109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60890344 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60761789 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60692832 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60134228 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59618193 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59557242 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59462711 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58913066 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58894696 |
| 118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58093910 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57849898 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.57446407 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56017922 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55367287 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55235316 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52652824 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52540671 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51840704 |
| 127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51392073 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51197989 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51022558 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50499105 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48566025 |
| 132 | Hepatitis B_Homo sapiens_hsa05161 | 0.46473880 |
| 133 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45992511 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.45650565 |
| 135 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45633411 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45584035 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | 0.45540505 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45496919 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.45412241 |
| 140 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43161416 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42585966 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39027971 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33011461 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32951707 |
| 145 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32724553 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32057976 |
| 147 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31666085 |
| 148 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31474070 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31030762 |
| 150 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30369821 |
| 151 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28752444 |
| 152 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28407595 |
| 153 | Mineral absorption_Homo sapiens_hsa04978 | 0.27429931 |

